BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3742389)

  • 1. Factors that determine refractoriness of ascites to conventional therapy.
    Amra S; Elie R; Kronborg I
    CMAJ; 1986 Sep; 135(5):481-6. PubMed ID: 3742389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of serum-ascites albumin gradient for the determination of portal hypertension in the diagnosis of ascites.
    Dittrich S; Yordi LM; de Mattos AA
    Hepatogastroenterology; 2001; 48(37):166-8. PubMed ID: 11268957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory ascites in chronic dialysis patients.
    Gutch CF; Mahony JF; Pingerra W; Holmes JH; Ramirez G; Ogden DA
    Clin Nephrol; 1974; 2(2):59-62. PubMed ID: 4830513
    [No Abstract]   [Full Text] [Related]  

  • 4. Refractory ascites due to portal vein thrombosis in liver cirrhosis--report of two cases.
    Tanaka H; Horie Y; Idobe Y; Murawaki Y; Suou T; Kawasaki H
    Hepatogastroenterology; 1998; 45(23):1777-80. PubMed ID: 9840147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between increased colloid osmotic pressure and the resolution of refractory ascites after transjugular intrahepatic portosystemic shunt.
    Schiano TD; Black M; Hills C; Ter H; Bellary S; Miller LS
    South Med J; 2000 Mar; 93(3):305-9. PubMed ID: 10728519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver resection and intractable postoperative ascites.
    Ikeda Y; Kanematsu T; Matsumata T; Shimada M; Yamagata M; Sugimachi K
    Hepatogastroenterology; 1993 Feb; 40(1):14-6. PubMed ID: 8462921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
    Nair S; Singh R; Yoselewitz M
    J Vasc Interv Radiol; 2004 Dec; 15(12):1431-4. PubMed ID: 15590801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splanchnic hemodynamic factors in cirrhosis with refractory ascites.
    Lebrec D; Kotelanski B; Cohn JN
    J Lab Clin Med; 1979 Feb; 93(2):301-9. PubMed ID: 429841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endogenous digitalis-like factor in liver cirrhosis and cholestasis].
    Behrens R; Glauck D; Kaltenborn G; Behrens B; Wache H; Schlee H; Rink C; Böhme I; Nilius R
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():20-3. PubMed ID: 7483706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MELD score in advanced liver disease: association with clinical portal hypertension and mortality.
    Saab S; Landaverde C; Ibrahim AB; Durazo F; Han S; Yersiz H; Farmer DG; Ghobrial RM; Goldstein LI; Tong MJ; Busuttil RW
    Exp Clin Transplant; 2006 Jun; 4(1):395-9. PubMed ID: 16827633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatogenic ascites: pathogenesis and management.
    Pearlman DM
    N Y State J Med; 1968 Jul; 68(13):1837-42. PubMed ID: 4873502
    [No Abstract]   [Full Text] [Related]  

  • 12. Ascites in the state of Qatar: aetiology and diagnostic value of ascitic fluid analysis.
    Khan FY
    Singapore Med J; 2007 May; 48(5):434-9. PubMed ID: 17453102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
    Membreno F; Baez AL; Pandula R; Walser E; Lau DT
    J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Diuretic-resistant' ascites. Observations on pathogenesis.
    Rector WG
    Arch Intern Med; 1986 Aug; 146(8):1597-600. PubMed ID: 3729643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic of ascites due to portal hypertension: accuracy of the serum-ascites albumin gradient and protein analises in ascitic fluid].
    Rodríguez Vargas BO; Monge Salgado E; Montes Teves P; Salazar Ventura S; Guzmán Calderón E
    Rev Gastroenterol Peru; 2014; 34(1):23-8. PubMed ID: 24721954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Transjugular intrahepatic portosystemic shunt in the treatment of refractory ascites in 21 patients].
    Vandistel G; Nevens F; Stockx L; Raat H; Wilms G; Fevery J
    Ned Tijdschr Geneeskd; 1996 Dec; 140(49):2455-8. PubMed ID: 8999346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum-ascites albumin concentration gradient: a physiologic approach to the differential diagnosis of ascites.
    Paré P; Talbot J; Hoefs JC
    Gastroenterology; 1983 Aug; 85(2):240-4. PubMed ID: 6862152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of ascites in the patient with portal hypertension with emphasis on spontaneous bacterial peritonitis.
    Navasa M; Rodés J
    Semin Gastrointest Dis; 1997 Oct; 8(4):200-9. PubMed ID: 9360284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology and management of portal hypertension. 2: Cirrhotic ascites.
    Stanley AJ; Bouchier IA; Hayes PC
    Br J Hosp Med; 1997 Jul 9-Aug 19; 58(2-3):74-8. PubMed ID: 9349370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.